Integrin αvβ5-mediated TGF-β activation by airway smooth muscle cells in asthma

Journal of Immunology

Volumn 187, Issue 11, 2011, Pages 6094-6107

  Tatler, Amanda L ^a   John, Alison E ^a   Jolly, Lisa ^a   Habgood, Anthony ^a   Porte, Jo ^a   Brightling, Chris ^b   Knox, Alan J ^a   Pang, Linhua ^a   Sheppard, Dean ^c   Huang, Xiaozhu ^c   Jenkins, Gisli ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAVBETA5 INTEGRIN; COLLAGEN TYPE 1; CYTOCHALASIN D; FORMOTEROL; LYSOPHOSPHATIDIC ACID; MESSENGER RNA; METHACHOLINE; TRANSFORMING GROWTH FACTOR BETA;

AIRWAY REMODELING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLUS FUMIGATUS; ASTHMA; BRONCHODILATATION; BRONCHOSPASM; CELL ACTIVATION; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERTROPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER;

AIRWAY REMODELING; ANIMALS; ASTHMA; BLOTTING, WESTERN; CELL LINE; CELL SEPARATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MICE; MYOCYTES, SMOOTH MUSCLE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, VITRONECTIN; RESPIRATORY SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 82755189233     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003507     Document Type: Article

References (60)

1. Benayoun, L., A. Druilhe, M. C. Dombret, M. Aubier, and M. Pretolani. 2003. Airway structural alterations selectively associated with severe asthma. Am. J. Respir. Crit. Care Med. 167: 1360-1368. (Pubitemid 36609720)
2. Lange, P., J. Parner, J. Vestbo, P. Schnohr, and G. Jensen. 1998. A 15-year follow-up study of ventilatory function in adults with asthma. N. Engl. J. Med. 339: 1194-1200.
3. Silva, P. L., C. P. Passaro, V. R. Cagido, M. Bozza, M. Dolhnikoff, E. M. Negri, M. M. Morales, V. L. Capelozzi, W. A. Zin, and P. R. Rocco. 2008. Impact of lung remodelling on respiratory mechanics in a model of severe allergic inflammation. Respir. Physiol. Neurobiol. 160: 239-248. (Pubitemid 351754798)
4. Grainge, C. L., L. C. Lau, J. A. Ward, V. Dulay, G. Lahiff, S. Wilson, S. Holgate, D. E. Davies, and P. H. Howarth. 2011. Effect of bronchoconstriction on airway remodeling in asthma. N. Engl. J. Med. 364: 2006-2015.
5. Boxall, C., S. T. Holgate, and D. E. Davies. 2006. The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma. Eur. Respir. J. 27: 208-229. (Pubitemid 43092684)
6. Coutts, A., G. Chen, N. Stephens, S. Hirst, D. Douglas, T. Eichholtz, and N. Khalil. 2001. Release of biologically active TGF-beta from airway smooth muscle cells induces autocrine synthesis of collagen. Am. J. Physiol. Lung Cell. Mol. Physiol. 280: L999-L1008.
7. Moir, L. M., J. K. Burgess, and J. L. Black. 2008. Transforming growth factor beta 1 increases fibronectin deposition through integrin receptor alpha 5 beta 1 on human airway smooth muscle. J. Allergy Clin. Immunol. 121: 1034-1039. e1034.
8. Kucich, U., J. C. Rosenbloom, G. Shen, W. R. Abrams, A. D. Hamilton, S. M. Sebti, and J. Rosenbloom. 2000. TGF-beta1 stimulation of fibronectin transcription in cultured human lung fibroblasts requires active geranylgeranyl transferase I, phosphatidylcholine-specific phospholipase C, protein kinase C-delta, and p38, but not erk1/erk2. Arch. Biochem. Biophys. 374: 313-324. (Pubitemid 30120268)
9. McMillan, S. J., G. Xanthou, and C. M. Lloyd. 2005. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J. Immunol. 174: 5774-5780. (Pubitemid 40593221)
10. Gregory, L. G., S. A. Mathie, S. A. Walker, S. Pegorier, C. P. Jones, and C. M. Lloyd. 2010. Overexpression of Smad2 drives house dust mite-mediated airway remodeling and airway hyperresponsiveness via activin and IL-25. Am. J. Respir. Crit. Care Med. 182: 143-154.
11. Moffatt, M. F., I. G. Gut, F. Demenais, D. P. Strachan, E. Bouzigon, S. Heath, E. von Mutius, M. Farrall, M. Lathrop, W. O. Cookson; GABRIEL Consortium. 2010. A large-scale, consortium-based genomewide association study of asthma. N. Engl. J. Med. 363: 1211-1221.
12. Annes, J. P., J. S. Munger, and D. B. Rifkin. 2003. Making sense of latent TGFbeta activation. J. Cell Sci. 116: 217-224. (Pubitemid 36163863)
13. Lyons, R. M., L. E. Gentry, A. F. Purchio, and H. L. Moses. 1990. Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J. Cell Biol. 110: 1361-1367.
14. Yu, Q., and I. Stamenkovic. 2000. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 14: 163-176. (Pubitemid 30070982)
15. Tatler, A. L., J. Porte, A. Knox, G. Jenkins, and L. Pang. 2008. Tryptase activates TGFbeta in human airway smooth muscle cells via direct proteolysis. Biochem. Biophys. Res. Commun. 370: 239-242.
16. Brown, P. D., L. M. Wakefield, A. D. Levinson, and M. B. Sporn. 1990. Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors 3: 35-43. (Pubitemid 20265013)
17. Ribeiro, S. M., M. Poczatek, S. Schultz-Cherry, M. Villain, and J. E. Murphy-Ullrich. 1999. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J. Biol. Chem. 274: 13586-13593.
18. Torrego, A., M. Hew, T. Oates, M. Sukkar, and K. Fan Chung. 2007. Expression and activation of TGF-beta isoforms in acute allergen-induced remodelling in asthma. Thorax 62: 307-313. (Pubitemid 46580573)
19. Sagara, H., T. Okada, K. Okumura, H. Ogawa, C. Ra, T. Fukuda, and A. Nakao. 2002. Activation of TGF-beta/Smad2 signaling is associated with airway remodeling in asthma. J. Allergy Clin. Immunol. 110: 249-254.
20. Lee, S. Y., J. S. Kim, J. M. Lee, S. S. Kwon, K. H. Kim, H. S. Moon, J. S. Song, S. H. Park, and Y. K. Kim. 2008. Inhaled corticosteroid prevents the thickening of airway smooth muscle in murine model of chronic asthma. Pulm. Pharmacol. Ther. 21: 14-19.
21. Howat, W. J., S. T. Holgate, and P. M. Lackie. 2002. TGF-beta isoform release and activation during in vitro bronchial epithelial wound repair. Am. J. Physiol. Lung Cell. Mol. Physiol. 282: L115-L123. (Pubitemid 34654188)
22. Lindstedt, K. A., Y. Wang, N. Shiota, J. Saarinen, M. Hyytiäinen, J. O. Kokkonen, J. Keski-Oja, and P. T. Kovanen. 2001. Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. FASEB J. 15: 1377-1388. (Pubitemid 32531815)
23. Woodman, L., S. Siddiqui, G. Cruse, A. Sutcliffe, R. Saunders, D. Kaur, P. Bradding, and C. Brightling. 2008. Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF-beta 1. J. Immunol. 181: 5001-5007.
24. Yang, Z., Z. Mu, B. Dabovic, V. Jurukovski, D. Yu, J. Sung, X. Xiong, and J. S. Munger. 2007. Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice. J. Cell Biol. 176: 787-793. (Pubitemid 46425539)
25. Aluwihare, P., Z. Mu, Z. Zhao, D. Yu, P. H.Weinreb, G. S. Horan, S. M. Violette, and J. S. Munger. 2009. Mice that lack activity of alphavbeta6- and alphavbeta8-integrins reproduce the abnormalities of Tgfb1- and Tgfb3-null mice. J. Cell Sci. 122: 227-232.
26. Kitamura, H., S. Cambier, S. Somanath, T. Barker, S. Minagawa, J. Markovics, A. Goodsell, J. Publicover, L. Reichardt, D. Jablons, et al. 2011. Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin αvβ8-mediated activation of TGF-β. J. Clin. Invest. 121: 2863-2875.
27. Munger, J. S., X. Huang, H. Kawakatsu, M. J. Griffiths, S. L. Dalton, J. Wu, J. F. Pittet, N. Kaminski, C. Garat, M. A. Matthay, et al. 1999. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328. (Pubitemid 29077586)
28. Mu, D., S. Cambier, L. Fjellbirkeland, J. L. Baron, J. S. Munger, H. Kawakatsu, D. Sheppard, V. C. Broaddus, and S. L. Nishimura. 2002. The integrin alpha(v) beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J. Cell Biol. 157: 493-507. (Pubitemid 34839812)
29. Asano, Y., H. Ihn, K. Yamane, M. Jinnin, Y. Mimura, and K. Tamaki. 2005. Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts. J. Immunol. 175: 7708-7718. (Pubitemid 41713471)
30. Wipff, P. J., D. B. Rifkin, J. J. Meister, and B. Hinz. 2007. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J. Cell Biol. 179: 1311-1323. (Pubitemid 350277747)
31. Jenkins, R. G., X. Su, G. Su, C. J. Scotton, E. Camerer, G. J. Laurent, G. E. Davis, R. C. Chambers, M. A. Matthay, and D. Sheppard. 2006. Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J. Clin. Invest. 116: 1606-1614.
32. Xu, M. Y., J. Porte, A. J. Knox, P. H. Weinreb, T. M. Maher, S. M. Violette, R. J. McAnulty, D. Sheppard, and R. G. Jenkins. 2009. Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein Galphaq. Am. J. Pathol. 174: 1264-1279.
33. Asano, Y., H. Ihn, K. Yamane, M. Jinnin, Y. Mimura, and K. Tamaki. 2005. Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts. Arthritis Rheum. 52: 2897-2905. (Pubitemid 41369121)
34. Scotton, C. J., M. A. Krupiczojc, M. Königshoff, P. F. Mercer, Y. C. Lee, N. Kaminski, J. Morser, J. M. Post, T. M. Maher, A. G. Nicholson, et al. 2009. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J. Clin. Invest. 119: 2550-2563.
35. Pang, L., and A. J. Knox. 1997. Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells. Br. J. Pharmacol. 121: 579-587. (Pubitemid 27226313)
36. Kaur, D., R. Saunders, P. Berger, S. Siddiqui, L. Woodman, A. Wardlaw, P. Bradding, and C. E. Brightling. 2006. Airway smooth muscle and mast cell-derived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma. Am. J. Respir. Crit. Care Med. 174: 1179-1188. (Pubitemid 44924818)
37. Weglarz, L., I. Molin, A. Orchel, B. Parfiniewicz, and Z. Dzierzewicz. 2006. Quantitative analysis of the level of p53 and p21(WAF1) mRNA in human colon cancer HT-29 cells treated with inositol hexaphosphate. Acta Biochim. Pol. 53: 349-356. (Pubitemid 44033933)
38. Clifford, R. L., K. Deacon, and A. J. Knox. 2008. Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, AND GSK3(beta). J. Biol. Chem. 283: 35337-35353.
39. John, A. E., Y. M. Zhu, C. E. Brightling, L. Pang, and A. J. Knox. 2009. Human airway smooth muscle cells from asthmatic individuals have CXCL8 hypersecretion due to increased NF-kappa B p65, C/EBP beta, and RNA polymerase II binding to the CXCL8 promoter. J. Immunol. 183: 4682-4692.
40. Huang, X., M. Griffiths, J. Wu, R. V. Farese, Jr., and D. Sheppard. 2000. Normal development, wound healing, and adenovirus susceptibility in beta5-deficient mice. Mol. Cell. Biol. 20: 755-759. (Pubitemid 30044211)
41. Gordon, E. D., S. S. Sidhu, Z.-E. Wang, P. G. Woodruff, S. Yuan, M. C. Solon, S. J. Conway, X. Huang, R. M. Locksley, and J. V. Fahy. 2011. A protective role for periostin in IgE mediated allergy and airway hyper-responsiveness. Clin. Exp. Allergy. DOI: 10.1111/j.1365-2222.2011.03840.x.
42. Sera, T., K. Uesugi, R. Himeno, and N. Yagi. 2007. Small airway changes in healthy and ovalbumin-treated mice during quasi-static lung inflation. Respir. Physiol. Neurobiol. 156: 304-311. (Pubitemid 46436604)
43. Kawahara, E., A. Saito, J. Kobayashi, S. Maenaka, T. Minamoto, M. A. Imai, and Y. Oda. 2005. Adhesiveness of beta5 integrin variant lacking FNK767-769 is similar to that of the prototype containing FNKFNK764-769. Cell Biol. Int. 29: 521-528. (Pubitemid 41138214)
44. Asano, Y., H. Ihn, K. Yamane, M. Jinnin, and K. Tamaki. 2006. Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fibroblasts. Am. J. Path. 168: 499-510. (Pubitemid 43271148)
45. Toews, M. L., E. E. Ustinova, and H. D. Schultz. 1997. Lysophosphatidic acid enhances contractility of isolated airway smooth muscle. J. Appl. Physiol. 83: 1216-1222. (Pubitemid 27433090)
46. Sakai, J., M. Oike, M. Hirakawa, and Y. Ito. 2003. Theophylline and cAMP inhibit lysophosphatidic acid-induced hyperresponsiveness of bovine tracheal smooth muscle cells. J. Physiol. 549: 171-180. (Pubitemid 36626406)
47. Bai, Y., and M. J. Sanderson. 2009. The contribution of Ca2+ signaling and Ca2+ sensitivity to the regulation of airway smooth muscle contraction is different in rats and mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 296: L947-L958.
48. Calderwood, D. A., R. Zent, R. Grant, D. J. Rees, R. O. Hynes, and M. H. Ginsberg. 1999. The Talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J. Biol. Chem. 274: 28071-28074.
49. Sheppard, D. 2005. Integrin-mediated activation of latent transforming growth factor beta. Cancer Metastasis Rev. 24: 395-402. (Pubitemid 41569979)
50. Ammit, A. J., C. L. Armour, and J. L. Black. 2000. Smooth-muscle myosin light-chain kinase content is increased in human sensitized airways. Am. J. Respir. Crit. Care Med. 161: 257-263. (Pubitemid 30055934)
51. Bramley, A. M., R. J. Thomson, C. R. Roberts, and R. R. Schellenberg. 1994. Hypothesis: excessive bronchoconstriction in asthma is due to decreased airway elastance. Eur. Respir. J. 7: 337-341. (Pubitemid 24138002)
52. Thomson, R. J., A. M. Bramley, and R. R. Schellenberg. 1996. Airway muscle stereology: implications for increased shortening in asthma. Am. J. Respir. Crit. Care Med. 154: 749-757. (Pubitemid 26327301)
53. Rosendahl, A., D. Checchin, T. E. Fehniger, P. ten Dijke, C. H. Heldin, and P. Sideras. 2001. Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation. Am. J. Respir. Cell Mol. Biol. 25: 60-68. (Pubitemid 32682706)
54. Dekkers, B. G., I. S. Bos, R. Gosens, A. J. Halayko, J. Zaagsma, and H. Meurs. 2010. The integrin-blocking peptide RGDS inhibits airway smooth muscle remodeling in a guinea pig model of allergic asthma. Am. J. Respir. Crit. Care Med. 181: 556-565.
55. Humbles, A. A., C. M. Lloyd, S. J. McMillan, D. S. Friend, G. Xanthou, E. E. McKenna, S. Ghiran, N. P. Gerard, C. Yu, S. H. Orkin, and C. Gerard. 2004. A critical role for eosinophils in allergic airways remodeling. Science 305: 1776-1779. (Pubitemid 39249645)
56. Flood-Page, P., A. Menzies-Gow, S. Phipps, S. Ying, A. Wangoo, M. S. Ludwig, N. Barnes, D. Robinson, and A. B. Kay. 2003. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J. Clin. Invest. 112: 1029-1036. (Pubitemid 38056318)
57. Boulet, L. P., M. Laviolette, H. Turcotte, A. Cartier, M. Dugas, J. L. Malo, and M. Boutet. 1997. Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine. Chest 112: 45-52. (Pubitemid 27343598)
58. Gosens, R., I. S. Bos, J. Zaagsma, and H. Meurs. 2005. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am. J. Respir. Crit. Care Med. 171: 1096-1102. (Pubitemid 40663720)
59. Kulkarni, A. B., C. G. Huh, D. Becker, A. Geiser, M. Lyght, K. C. Flanders, A. B. Roberts, M. B. Sporn, J. M. Ward, and S. Karlsson. 1993. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90: 770-774. (Pubitemid 23028947)
60. Leung, S. Y., A. Niimi, A. Noble, T. Oates, A. S. Williams, S. Medicherla, A. A. Protter, and K. F. Chung. 2006. Effect of transforming growth factor-beta receptor I kinase inhibitor 2,4-disubstituted pteridine (SD-208) in chronic allergic airway inflammation and remodeling. J. Pharmacol. Exp. Ther. 319: 586-594.